about
Distribution of CD4(pos) -, CD8(pos) - and regulatory T cells in the upper and lower gastrointestinal tract in healthy young subjects.Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trialEffects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract.Home Use of an Artificial Beta Cell in Type 1 DiabetesDay-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.Factors Affecting Recruitment of Participants for Studies of Diabetes Technology in Newly Diagnosed Youth with Type 1 Diabetes: A Qualitative Focus Group Study with Parents and Children.Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3-6 years: comparison between diluted and standard insulin strength.Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes.Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel sHome Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial.Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes.Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial.Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes.Reduction in Diabetic Ketoacidosis and Severe Hypoglycemia in Pediatric Type 1 Diabetes During the First Year of Continuous Glucose Monitoring: A Multicenter Analysis of 3,553 Subjects From the DPV Registry
P50
Q35050631-FAD22F98-22F0-4E5F-BED4-7267E535BCCFQ35153007-5197A5D5-F9BE-4F12-B41D-3C42669EB9DDQ35679288-1EE4AD60-AA17-4448-B4B2-6830B9619DB8Q36419734-976559C4-5BB7-4BFE-A6FF-3A8C894DD683Q37025568-58CB4F73-4374-44EE-9803-CE101597D340Q37280505-420EF0E7-358E-4B5A-AD83-6DDE0979DCACQ37736558-590237A4-A0F4-4F72-8205-812A2083DB6DQ38205861-51A4EC61-161B-44D4-A9FC-3BCDCC96335CQ38419059-E88F157E-9F99-43C9-AF9A-3744E4E97EF3Q38858904-C0D87885-EC5F-4AC0-99C6-19E0FA3B77E6Q38861338-9D3B55E5-FB18-480E-9E70-61DD14C58EF7Q39436182-AA512B0A-F921-4AA0-A010-CA89EEDAD877Q42718199-32B2C6C0-DF71-4B7A-A7F6-D81A15AB0787Q43145901-502950D2-CBF0-4932-B79C-200A3A8C1E1EQ44372769-DA16AE1F-16B1-4A06-B52F-067080942318Q47721261-5EEC75DF-6864-4D61-B27D-4080F1A7536DQ92858563-58C69D2B-E74A-411D-AA40-D5A512F28560
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Martin Tauschmann
@ast
Martin Tauschmann
@en
Martin Tauschmann
@es
Martin Tauschmann
@nl
type
label
Martin Tauschmann
@ast
Martin Tauschmann
@en
Martin Tauschmann
@es
Martin Tauschmann
@nl
prefLabel
Martin Tauschmann
@ast
Martin Tauschmann
@en
Martin Tauschmann
@es
Martin Tauschmann
@nl
P106
P31
P496
0000-0002-2305-2490